News

BioNTech has agreed to pay UK drugmaker GSK royalties on its Covid-19 and influenza vaccines as part of a patent settlement with CureVac, in a deal that allows the biotech to move forward with the ...
American pharmaceutical giant Pfizer and German biotech firm BioNTech will pay Britain's GSK and Germany's CureVac US$740 million plus royalties to ...
Patients in England with head and neck cancer will be fast-tracked onto a clinical trial for a "potentially transformative" new vaccine, under an initiative announced by the NHS. The first patients ...
Robert F. Kennedy Jr., the HHS Secretary of the US, despite a long history of the contray, now often pretends to be not against vaccinations. Yet, his recent actions depict an entirely different ...